BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22310732)

  • 1. Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients.
    Quaglino P; Antiga E; Comessatti A; Caproni M; Nardò T; Ponti R; Novelli M; Osella-Abate S; Fabbri P; Bernengo MG
    Arch Dermatol Res; 2012 Oct; 304(8):639-45. PubMed ID: 22310732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid.
    Rensing-Ehl A; Gaus B; Bruckner-Tuderman L; Martin SF
    Exp Dermatol; 2007 Jan; 16(1):13-21. PubMed ID: 17181632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
    Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG
    Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25- FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia.
    Toldi G; Saito S; Shima T; Halmos A; Veresh Z; Vásárhelyi B; Rigó J; Molvarec A
    Am J Reprod Immunol; 2012 Aug; 68(2):175-80. PubMed ID: 22510013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid.
    Antiga E; Quaglino P; Volpi W; Pierini I; Del Bianco E; Bianchi B; Novelli M; Savoia P; Bernengo MG; Fabbri P; Caproni M
    J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):222-30. PubMed ID: 23331964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma.
    Meloni F; Morosini M; Solari N; Passadore I; Nascimbene C; Novo M; Ferrari M; Cosentino M; Marino F; Pozzi E; Fietta AM
    Hum Immunol; 2006; 67(1-2):1-12. PubMed ID: 16698419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28.
    Sempere-Ortells JM; Pérez-García V; Marín-Alberca G; Peris-Pertusa A; Benito JM; Marco FM; Zubcoff JJ; Navarro-Blasco FJ
    Autoimmunity; 2009; 42(8):636-45. PubMed ID: 19886735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lesional Th17 cells and regulatory T cells in bullous pemphigoid.
    Arakawa M; Dainichi T; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Tsuruta D; Hashimoto T
    Exp Dermatol; 2011 Dec; 20(12):1022-4. PubMed ID: 22017210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating naïve and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis.
    Miyoshi H; Uchida K; Taniguchi T; Yazumi S; Matsushita M; Takaoka M; Okazaki K
    Pancreas; 2008 Mar; 36(2):133-40. PubMed ID: 18376303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
    J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells.
    Duggleby RC; Shaw TN; Jarvis LB; Kaur G; Gaston JS
    Immunology; 2007 May; 121(1):129-39. PubMed ID: 17425604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
    Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
    Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric analyses of circulating regulatory T cells in patients with dermatitis herpetiformis and other immune mediated dermatoses.
    Quaglino P; Ponti R; Novelli M; Savoia P; Fava P; Papini M; Bernengo MG
    G Ital Dermatol Venereol; 2013 Apr; 148(2):197-201. PubMed ID: 23588145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.
    Peiseler M; Sebode M; Franke B; Wortmann F; Schwinge D; Quaas A; Baron U; Olek S; Wiegard C; Lohse AW; Weiler-Normann C; Schramm C; Herkel J
    J Hepatol; 2012 Jul; 57(1):125-32. PubMed ID: 22425700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
    Xing Q; Su H; Cui J; Wang B
    Immunol Invest; 2012; 41(1):15-27. PubMed ID: 21563925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy.
    Sanvito L; Makowska A; Gregson N; Nemni R; Hughes RA
    Autoimmunity; 2009; 42(8):667-77. PubMed ID: 19886739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
    Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
    Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden.
    Feyler S; von Lilienfeld-Toal M; Jarmin S; Marles L; Rawstron A; Ashcroft AJ; Owen RG; Selby PJ; Cook G
    Br J Haematol; 2009 Mar; 144(5):686-95. PubMed ID: 19133978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis.
    McKay FC; Swain LI; Schibeci SD; Rubio JP; Kilpatrick TJ; Heard RN; Stewart GJ; Booth DR
    J Autoimmun; 2008 Aug; 31(1):52-8. PubMed ID: 18406576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.